Our research into different forms of cancer

Need to know more about research we're doing into a specific type of cancer affecting you, a friend or a loved one? We can tell you about how we've changed diagnosis and treatment for people with many different types of cancer and provide information about our latest discoveries.

Choose a type of cancer

We’re leading research across all major forms of cancer. Find out some of our top breakthroughs and what we're currently researching.

Clinical Trials at ICR-CTSU

Our Clinical Trials & Statistics Unit (ICR-CTSU) regularly recruits across various cancer types to test drugs, screening methods and more
More about out trials

Help more women survive cancer

Give the gift of research to help someone's mum, sister, nan, or friend survive cancer and look forward to spending more precious time with their loved ones.
Support our appeal

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With Gift Aid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With Gift Aid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Targeting SRC in G4-Medulloblastoma

Primary supervisor: Dr Rob Van Montfort and Dr Gary Newton Primary site: Sutton Funded by Cancer Research UK-CBTCE (Paul Workman) Targeting SRC in G4-Medulloblastoma

See full project details

Our very latest cancer discoveries & news

ICR scientists unveil AI-powered platform that helps researchers speed up biomarker discoveries for personalised cancer treatment

02/04/25

An ICR team has unveiled a cutting-edge research platform powered by artificial intelligence (AI) that will revolutionise cancer research by allowing researchers to integrate and analyse large and complex clinical trial datasets, speeding up the discovery of new cancer biomarkers.
See full story
New study confirms hormone’s role in post-menopausal breast cancer risk

02/04/25

In the largest and most comprehensive study of its kind, researchers have provided further evidence that a hormone responsible for regulating breast development acts as a risk factor for breast cancer in post-menopausal women.
See full story
Mini tumours grown from a bowel cancer
£5.5m research funding to transform bowel cancer care

30/03/25

Scientists from The Institute of Cancer Research, London, are part of a team of international researchers who have secured £5.5million in funding to find smarter, kinder treatments for people living with bowel cancer.
See full story
A high magnification image of ovarian clear cell carcinoma (photo: Nephron)
Newly identified biomarker could improve treatment for people with rare type of ovarian cancer

26/03/25

Scientists at The Institute of Cancer Research, London, have identified a gene that affects how ovarian clear cell carcinoma (OCCC) could respond to a new class of drug called ATR inhibitors.
See full story